Coste del desperdicio de tratamiento en niños tratados con hormona de crecimiento humana recombinante administrada a través de diferentes dispositivos en España

This study compares the annual wastage costs of r-hGH treatment administered with Easypod® versus other approved devices in Spain.

Authors: María Dolores Edo, Olga Durán Morán, Carla Gari Peris; Olga Ojeda Rife, Jose Luis Poveda

Year: 2023

Congress: XLII Jornadas de Economía de la Salud


Outside URL
Subscribe to Outcomes´10
Todos los campos marcados con un * son obligatorios
Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy
Logotipo
Aenor gestión de calidad
Aenor seguridad e información
Logotipo
Skip to content